DE69118847T2 - Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus - Google Patents

Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus

Info

Publication number
DE69118847T2
DE69118847T2 DE69118847T DE69118847T DE69118847T2 DE 69118847 T2 DE69118847 T2 DE 69118847T2 DE 69118847 T DE69118847 T DE 69118847T DE 69118847 T DE69118847 T DE 69118847T DE 69118847 T2 DE69118847 T2 DE 69118847T2
Authority
DE
Germany
Prior art keywords
heptastigmine
icus
treat cerebral
cerebral
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69118847T
Other languages
English (en)
Other versions
DE69118847D1 (de
Inventor
Bono Rinaldo Del
Bruno Pietro Imbimbo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mediolanum Farmaceutici SpA
Original Assignee
Mediolanum Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mediolanum Farmaceutici SpA filed Critical Mediolanum Farmaceutici SpA
Application granted granted Critical
Publication of DE69118847D1 publication Critical patent/DE69118847D1/de
Publication of DE69118847T2 publication Critical patent/DE69118847T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
DE69118847T 1990-12-21 1991-12-18 Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus Expired - Fee Related DE69118847T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT02251390A IT1246050B (it) 1990-12-21 1990-12-21 Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.

Publications (2)

Publication Number Publication Date
DE69118847D1 DE69118847D1 (de) 1996-05-23
DE69118847T2 true DE69118847T2 (de) 1996-09-05

Family

ID=11197279

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69118847T Expired - Fee Related DE69118847T2 (de) 1990-12-21 1991-12-18 Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus

Country Status (9)

Country Link
EP (1) EP0492383B1 (de)
JP (1) JPH04308529A (de)
KR (1) KR920011482A (de)
AT (1) ATE136776T1 (de)
CA (1) CA2058228A1 (de)
DE (1) DE69118847T2 (de)
ES (1) ES2085411T3 (de)
IE (1) IE914463A1 (de)
IT (1) IT1246050B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100908068B1 (ko) * 2008-12-31 2009-07-15 주식회사 비케이티 대리석 석판, 대리석 석판 가공장치 및 그 가공방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione

Also Published As

Publication number Publication date
IE914463A1 (en) 1992-07-01
DE69118847D1 (de) 1996-05-23
KR920011482A (ko) 1992-07-24
JPH04308529A (ja) 1992-10-30
IT9022513A1 (it) 1992-06-21
ES2085411T3 (es) 1996-06-01
EP0492383A1 (de) 1992-07-01
CA2058228A1 (en) 1992-06-22
ATE136776T1 (de) 1996-05-15
IT9022513A0 (it) 1990-12-21
IT1246050B (it) 1994-11-07
EP0492383B1 (de) 1996-04-17

Similar Documents

Publication Publication Date Title
DE69230046D1 (de) 2-Bromomelatonin zur Behandlung von Schlafstörungen
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
ATE254926T1 (de) Verwendung eines consensus-interferons zur reduzierung der nebeneffekte in der interferon behandlung von viralen hepatiten.
DE3856594D1 (de) Mittel zur behandlung der alzheimer-krankheit
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
DE58902094D1 (de) Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
ATE67666T1 (de) Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
ATE174798T1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
DE3854121T2 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE69431199T2 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
ATE89737T1 (de) Behandlung von leukozytstoerungen mit gm-csf.
ATE239470T1 (de) Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
DE69313261T2 (de) Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS
DE3861494D1 (de) Pharmazeutische zusammensetzung zur behandlung von tumoren.
DK360884D0 (da) Farmaceutiske og veterinaere midler til behandling af iskaemiskehjertelidelser
DE69118847T2 (de) Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus
ATE69949T1 (de) Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
ATE229343T1 (de) Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs
DE59410340D1 (de) Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen
ATE75938T1 (de) Enantiomere des propafenons enthaltende therapeutische mittel.
ATE74755T1 (de) Verwendung von n-(1-allyl-2-pyrrolidinylmethyl)-2-methoxy-4-am no-5-methylsulfamoylbenzamid zur behandlung der parkinson-krankheit.
ATE88090T1 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
DE68906028T2 (de) Verwendung von acetyl-d-carnitin zur therapeutischen behandlung von glaukom.
ATA227483A (de) Vorrichtung zur kombinierten therapeutschischen und anregenden behandlung von zahnfleisch
ATE2999T1 (de) Xanthinderivate und pharmazeutische zusammensetzung zur verwendung fuer die behandlung chronischer verstopfungen der atemwege und von herzkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee